These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28821761)

  • 41. A net-shaped multicellular formation facilitates the maturation of hPSC-derived cardiomyocytes through mechanical and electrophysiological stimuli.
    Liu T; Huang C; Li H; Wu F; Luo J; Lu W; Lan F
    Aging (Albany NY); 2018 Apr; 10(4):532-548. PubMed ID: 29661985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TRPV-1-mediated elimination of residual iPS cells in bioengineered cardiac cell sheet tissues.
    Matsuura K; Seta H; Haraguchi Y; Alsayegh K; Sekine H; Shimizu T; Hagiwara N; Yamazaki K; Okano T
    Sci Rep; 2016 Feb; 6():21747. PubMed ID: 26888607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.
    Tachibana A; Santoso MR; Mahmoudi M; Shukla P; Wang L; Bennett M; Goldstone AB; Wang M; Fukushi M; Ebert AD; Woo YJ; Rulifson E; Yang PC
    Circ Res; 2017 Sep; 121(6):e22-e36. PubMed ID: 28743804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiomyocytes induced from hiPSCs by well-defined compounds have therapeutic potential in heart failure by secreting PDGF-BB.
    Li H; Wu F; Huang G; Wu D; Wang T; Wang X; Wang K; Feng Y; Xu A
    Signal Transduct Target Ther; 2022 Jul; 7(1):253. PubMed ID: 35902567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells.
    Bel A; Planat-Bernard V; Saito A; Bonnevie L; Bellamy V; Sabbah L; Bellabas L; Brinon B; Vanneaux V; Pradeau P; Peyrard S; Larghero J; Pouly J; Binder P; Garcia S; Shimizu T; Sawa Y; Okano T; Bruneval P; Desnos M; Hagège AA; Casteilla L; Pucéat M; Menasché P
    Circulation; 2010 Sep; 122(11 Suppl):S118-23. PubMed ID: 20837902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechano-Pharmacological Characterization of Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells.
    Goßmann M; Frotscher R; Linder P; Neumann S; Bayer R; Epple M; Staat M; Artmann AT; Artmann GM
    Cell Physiol Biochem; 2016; 38(3):1182-98. PubMed ID: 26983082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes.
    Funakoshi S; Miki K; Takaki T; Okubo C; Hatani T; Chonabayashi K; Nishikawa M; Takei I; Oishi A; Narita M; Hoshijima M; Kimura T; Yamanaka S; Yoshida Y
    Sci Rep; 2016 Jan; 6():19111. PubMed ID: 26743035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
    Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conduction and contraction properties of human iPS cell-derived cardiomyocytes: analysis by motion field imaging compared with the guinea-pig isolated heart model.
    Isobe T; Honda M; Komatsu R; Tabo M
    J Toxicol Sci; 2018; 43(8):493-506. PubMed ID: 30078835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional biological pacemaker generation by T-Box18 protein expression via stem cell and viral delivery approaches in a murine model of complete heart block.
    Gorabi AM; Hajighasemi S; Khori V; Soleimani M; Rajaei M; Rabbani S; Atashi A; Ghiaseddin A; Saeid AK; Ahmadi Tafti H; Sahebkar A
    Pharmacol Res; 2019 Mar; 141():443-450. PubMed ID: 30677516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human induced pluripotent stem cell-based platform for modeling cardiac ischemia.
    Häkli M; Kreutzer J; Mäki AJ; Välimäki H; Lappi H; Huhtala H; Kallio P; Aalto-Setälä K; Pekkanen-Mattila M
    Sci Rep; 2021 Feb; 11(1):4153. PubMed ID: 33603154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells.
    Xi J; Khalil M; Shishechian N; Hannes T; Pfannkuche K; Liang H; Fatima A; Haustein M; Suhr F; Bloch W; Reppel M; Sarić T; Wernig M; Jänisch R; Brockmeier K; Hescheler J; Pillekamp F
    FASEB J; 2010 Aug; 24(8):2739-51. PubMed ID: 20371616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model.
    Sugiura T; Hibino N; Breuer CK; Shinoka T
    J Cardiothorac Surg; 2016 Dec; 11(1):163. PubMed ID: 27906085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laminin α2-secreting fibroblasts enhance the therapeutic effect of skeletal myoblast sheets.
    Uchinaka A; Tasaka K; Mizuno Y; Maeno Y; Ban T; Mori S; Hamada Y; Miyagawa S; Saito A; Sawa Y; Matsuura N; Nagata K; Yamamoto H; Kawaguchi N
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):457-464. PubMed ID: 27663298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering.
    Haraguchi Y; Matsuura K; Shimizu T; Yamato M; Okano T
    J Tissue Eng Regen Med; 2015 Dec; 9(12):1363-75. PubMed ID: 23728860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of physiological matrix conditions on permanent culture of induced pluripotent stem cell-derived cardiomyocytes.
    Heras-Bautista CO; Katsen-Globa A; Schloerer NE; Dieluweit S; Abd El Aziz OM; Peinkofer G; Attia WA; Khalil M; Brockmeier K; Hescheler J; Pfannkuche K
    Biomaterials; 2014 Aug; 35(26):7374-85. PubMed ID: 24889032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation.
    Sharma A; Li G; Rajarajan K; Hamaguchi R; Burridge PW; Wu SM
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.